<DOC>
	<DOCNO>NCT00836745</DOCNO>
	<brief_summary>The Sutent® Observational Study propose assess real-world usage pattern effectiveness tolerability treatment Indian patient advance renal cell cancer Sutent® . Generation information expect aid everyday clinical decision-making Indian doctor add body generalizable evidence .</brief_summary>
	<brief_title>Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent</brief_title>
	<detailed_description>The assignment patient Sutent® treatment decide advance noninterventional study protocol , fall within current practice . The decision prescribe Sutent® clearly driven decision include patient study.The sample size study base statistical consideration . It expect minimum 100 patient enrol study end first year data collect would adequate fulfill observational objective study.The study initiate 10 site across India 1st year . The study may expand addition new site 2nd year .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients advance renal cell cancer Treatment naïve cytokine refractory Patients present know hypersensitivity Sunitinib metabolite</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Advanced renal cell Cancer</keyword>
	<keyword>Non interventional study</keyword>
	<keyword>Renal Cancer</keyword>
	<keyword>Sutent</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Advanced Renal Cell Carcinoma</keyword>
</DOC>